Supplementary Tables S1-S8 from Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table S1 - RT-PCR Primer sequences used in the study Supplementary Table S2 - CDK2 shRNA sequences used in the study Supplementary Table S3 - Cell lines and genes used in the analysis from Project Achilles Supplementary Table S4 - EC50 values for compounds from primary screen for OVCAR3 and SKOV3 cell lines Supplementary Table S5 - EC50 values for compounds from primary screen for OVCAR3 and OVCAR3-R1 cell lines Supplementary Table S7 - List of compounds and their primary targets tested in the secondary screen for OVCAR3 and OVCAR3-R1 cell lines Supplementary Table S8 - List of combination indexes and type of interaction between compounds tested in the matrix screen
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361885522